1.0Pharma Trendhttps://pharma-trend.com/enBusiness Wirehttps://pharma-trend.com/en/author/business/Tectonic Therapeutic Strengthens Leadership Team - Pharma Trendrich600338<blockquote class="wp-embedded-content" data-secret="i01PJqoZyI"><a href="https://pharma-trend.com/en/tectonic-therapeutic-strengthens-leadership-team/">Tectonic Therapeutic Strengthens Leadership Team</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://pharma-trend.com/en/tectonic-therapeutic-strengthens-leadership-team/embed/#?secret=i01PJqoZyI" width="600" height="338" title="“Tectonic Therapeutic Strengthens Leadership Team” — Pharma Trend" data-secret="i01PJqoZyI" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://pharma-trend.com/en/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
BOSTON–(BUSINESS WIRE)–Tectonic Therapeutic, Inc. a pre-clinical stage biotechnology company transforming the discovery of novel GPCR-targeted therapies (G-Protein Coupled Receptors), today announced the promotion of Senior Vice President, Head of Research, Peter McNamara, PhD, to Chief Scientific Officer as well as the appointments of Barry Rubenstein as Senior Vice President, People and Culture and Washington Alves ... [Read more...]https://mms.businesswire.com/media/20220719005158/en/1215374/21/Tectonic-Logo-full-color.jpg